Zoltias Plus Tablet contains a combination of Etizolam (0.5 mg) and Propranolol (20 mg), formulated to provide therapeutic benefits in the management of anxiety disorders and related conditions. Etizolam, a thienodiazepine derivative, exhibits anxiolytic, sedative, muscle relaxant, and anticonvulsant properties by modulating the gamma-aminobutyric acid (GABA) receptors in the central nervous system, thereby producing a calming effect. Propranolol, a non-selective beta-adrenergic blocker, reduces physical symptoms associated with anxiety such as tachycardia, tremors, and hypertension by blocking beta-1 and beta-2 adrenergic receptors. The combined action of these active ingredients makes Zoltias Plus effective in alleviating both the psychological and somatic manifestations of anxiety, including performance anxiety and panic attacks. This medication is indicated for short-term relief of anxiety symptoms, essential tremors, and situational anxiety. It should be used under strict medical supervision, especially in patients with respiratory conditions, cardiovascular disorders, or hepatic impairment. Common side effects may include drowsiness, dizziness, hypotension, and gastrointestinal disturbances. Patients are advised to avoid alcohol and operating heavy machinery while on this medication. Dosage and duration of treatment should be individualized based on clinical response and tolerability.